Dr. Lydia Gushgari, Ph.D., specializes in immunology, virology, vaccine development, cancer immunology, and autoimmunity. She earned a Ph.D. in Biological Design from Arizona State University and a B.S. in Microbiology/Molecular Genetics from Oklahoma State University. Her graduate research focused on scalable protein production for HIV vaccines, leading to Phase I clinical trials and a patent. Her postdoctoral studies examined the role of gamma-interferon-inducible lysosomal thiol reductase (GILT) in melanoma patient outcomes and immune system function. At Cyrex Laboratories, Dr. Gushgari supervised 19 CLIA laboratory-developed immunology tests and five FDA-approved assays, overseeing regulatory compliance, assay validation, and laboratory automation. She led the development of two CLIA-approved assays and managed proficiency testing, quality control, and operational efficiency improvements, including integrating ELISA automation and STARLIMS customization.
As Chief of Staff, she applies her expertise in protein purification, assay validation, and laboratory management to ensure high-quality technical development, compliance, and strategic growth. She also supports business strategy, outreach, and marketing efforts for commercial products and services.
Dr. Lydia Gushgari, Ph.D., specializes in immunology, virology, vaccine development, cancer immunology, and autoimmunity. She earned a Ph.D. in Biological Design from Arizona State University and a B.S. in Microbiology/Molecular Genetics from Oklahoma State University. Her graduate research focused on scalable protein production for HIV vaccines, leading to Phase I clinical trials and a patent. Her postdoctoral studies examined the role of gamma-interferon-inducible lysosomal thiol reductase (GILT) in melanoma patient outcomes and immune system function. At Cyrex Laboratories, Dr. Gushgari supervised 19 CLIA laboratory-developed immunology tests and five FDA-approved assays, overseeing regulatory compliance, assay validation, and laboratory automation. She led the development of two CLIA-approved assays and managed proficiency testing, quality control, and operational efficiency improvements, including integrating ELISA automation and STARLIMS customization.
As Chief of Staff, she applies her expertise in protein purification, assay validation, and laboratory management to ensure high-quality technical development, compliance, and strategic growth. She also supports business strategy, outreach, and marketing efforts for commercial products and services.